Juniper Biomedical

United States
Hodgkins, Illinois, United States, 01655

Company profile

Juniper Biomedical company profile

Juniper Biomedical is a medical device company that specializes in implantable neuromodulation technology. The company develops a micro-implant that delivers precision treatment for a spectrum of conditions in pelvic health. Juniper Biomedical’s micro-implantable neuromodulation technology can uniquely treat both stress and urge symptoms of urinary incontinence with a single micro-implant and a less invasive procedure than alternatives which only treat stress or urge independently.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
01655
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
10
Total equity funding
$2.1M
Last funding
Grant / $1.6M / 2025-10-20
Last equity funding
Seed / $2.1M
Investors
8
Lead investors
5
Founders
2
Articles
26

Founders and investors

Founders

David ConstantineMario Romero-Ortega

Lead investors

Auroral HoldingsMassachusetts Medical Device Development Center (M2D2)MassChallengeMedTech InnovatorNational Institutes of Health

Investors

Beacon AngelsHub Angels Investment GroupMassachusetts Medical Device Development Center (M2D2)MassChallengeNational Institutes of Health